Copyright Reports & Markets. All rights reserved.

Global Ambrisentan Drug Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Ambrisentan Drug Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 5 mg Tablet
      • 1.4.3 10 mg Tablet
    • 1.5 Market by Application
      • 1.5.1 Global Ambrisentan Drug Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Drug store
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Ambrisentan Drug Market Size
    • 2.2 Ambrisentan Drug Growth Trends by Regions
      • 2.2.1 Ambrisentan Drug Market Size by Regions (2014-2025)
      • 2.2.2 Ambrisentan Drug Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Ambrisentan Drug Market Size by Manufacturers
      • 3.1.1 Global Ambrisentan Drug Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Ambrisentan Drug Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Ambrisentan Drug Market Concentration Ratio (CR5 and HHI)
    • 3.2 Ambrisentan Drug Key Players Head office and Area Served
    • 3.3 Key Players Ambrisentan Drug Product/Solution/Service
    • 3.4 Date of Enter into Ambrisentan Drug Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Ambrisentan Drug Market Size by Type (2014-2019)
    • 4.2 Global Ambrisentan Drug Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Ambrisentan Drug Market Size (2014-2019)
    • 5.2 Ambrisentan Drug Key Players in United States
    • 5.3 United States Ambrisentan Drug Market Size by Type
    • 5.4 United States Ambrisentan Drug Market Size by Application

    6 Europe

    • 6.1 Europe Ambrisentan Drug Market Size (2014-2019)
    • 6.2 Ambrisentan Drug Key Players in Europe
    • 6.3 Europe Ambrisentan Drug Market Size by Type
    • 6.4 Europe Ambrisentan Drug Market Size by Application

    7 China

    • 7.1 China Ambrisentan Drug Market Size (2014-2019)
    • 7.2 Ambrisentan Drug Key Players in China
    • 7.3 China Ambrisentan Drug Market Size by Type
    • 7.4 China Ambrisentan Drug Market Size by Application

    8 Japan

    • 8.1 Japan Ambrisentan Drug Market Size (2014-2019)
    • 8.2 Ambrisentan Drug Key Players in Japan
    • 8.3 Japan Ambrisentan Drug Market Size by Type
    • 8.4 Japan Ambrisentan Drug Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Ambrisentan Drug Market Size (2014-2019)
    • 9.2 Ambrisentan Drug Key Players in Southeast Asia
    • 9.3 Southeast Asia Ambrisentan Drug Market Size by Type
    • 9.4 Southeast Asia Ambrisentan Drug Market Size by Application

    10 India

    • 10.1 India Ambrisentan Drug Market Size (2014-2019)
    • 10.2 Ambrisentan Drug Key Players in India
    • 10.3 India Ambrisentan Drug Market Size by Type
    • 10.4 India Ambrisentan Drug Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Ambrisentan Drug Market Size (2014-2019)
    • 11.2 Ambrisentan Drug Key Players in Central & South America
    • 11.3 Central & South America Ambrisentan Drug Market Size by Type
    • 11.4 Central & South America Ambrisentan Drug Market Size by Application

    12 International Players Profiles

    • 12.1 Gilead Sciences
      • 12.1.1 Gilead Sciences Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Ambrisentan Drug Introduction
      • 12.1.4 Gilead Sciences Revenue in Ambrisentan Drug Business (2014-2019)
      • 12.1.5 Gilead Sciences Recent Development
    • 12.2 GSK
      • 12.2.1 GSK Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Ambrisentan Drug Introduction
      • 12.2.4 GSK Revenue in Ambrisentan Drug Business (2014-2019)
      • 12.2.5 GSK Recent Development
    • 12.3 Hansoh Pharma
      • 12.3.1 Hansoh Pharma Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Ambrisentan Drug Introduction
      • 12.3.4 Hansoh Pharma Revenue in Ambrisentan Drug Business (2014-2019)
      • 12.3.5 Hansoh Pharma Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Ambrisentan (U.S. trade name Letairis; E.U. trade name Volibris; India trade name Pulmonext by MSN labs) is a drug indicated for use in the treatment of pulmonary hypertension.
      In 2018, the global Ambrisentan Drug market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Ambrisentan Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ambrisentan Drug development in United States, Europe and China.

      The key players covered in this study
      Gilead Sciences
      GSK
      Hansoh Pharma
      ...

      Market segment by Type, the product can be split into
      5 mg Tablet
      10 mg Tablet

      Market segment by Application, split into
      Hospital
      Drug store

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Ambrisentan Drug status, future forecast, growth opportunity, key market and key players.
      To present the Ambrisentan Drug development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Ambrisentan Drug are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now